Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "MedicationAdministration",
"id" : "OncologyMedicationAdministrationExample",
"meta" : {
"profile" : [
🔗 "https://fhir.dha.go.ke/nccp/StructureDefinition/nccp-oncology-medication-administration"
]
},
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Actual administration of Doxorubicin 105 mg IV (BSA 1.75 m²) on 15 Jan 2026, cycle 1</p></div>"
},
"extension" : [
{
"url" : "https://fhir.dha.go.ke/nccp/StructureDefinition/nccp-cycle-number-extension",
"valueInteger" : 1
},
{
"url" : "https://fhir.dha.go.ke/nccp/StructureDefinition/nccp-session-id-extension",
"valueString" : "SES-00231"
}
],
"status" : "completed",
"category" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/medication-admin-category",
"code" : "inpatient",
"display" : "Inpatient"
}
]
},
"medicationCodeableConcept" : {
"coding" : [
{
"system" : "https://fhir.dha.go.ke/terminology/CodeSystem/generic-products-cs",
"code" : "DOXORUBICIN",
"display" : "Doxorubicin"
}
]
},
"subject" : {
🔗 "reference" : "Patient/example-patient"
},
"context" : {
🔗 "reference" : "Encounter/example-encounter"
},
"effectiveDateTime" : "2026-01-15T10:30:00Z",
"performer" : [
{
"actor" : {
🔗 "reference" : "Practitioner/example-practitioner"
}
}
],
"request" : {
🔗 "reference" : "MedicationRequest/example-med-request-doxorubicin"
},
"dosage" : {
"route" : {
"coding" : [
{
"system" : "https://fhir.dha.go.ke/terminology/CodeSystem/med-admin-route-cs",
"code" : "IV-INFUSION-SHORT",
"display" : "IV Short Infusion"
}
]
},
"dose" : {
"value" : 105,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}
}